When the data sheet is absent or ambiguous, contact the manufacturer directly before proceeding
Indications and Usage Saxenda (liraglutide) injection 3 mg is indicated in combination with reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in: Adults and pediatric patients aged 12 years and older with body weight greater than 60kg and obesity Adults with overweight in the presence of at least one weight related comorbid condition Limitations of Use Saxenda contains liraglutide and should not be coadministered with other liraglutide-containing products or with any other GLP-1 receptor agonist The safety and effectiveness of Saxenda in pediatric patients with type 2 diabetes have not been established Reference 1
We found that LAC levels, and not those of free carnitine, were decreased in patients with MDD compared with age- and sex-matched healthy controls in two independent study centers
Batchuluun B, Pinkosky SL, Steinberg GR
The core of Mutant Creakong Cx8 is its unique triple creatine blend, featuring creatine monohydrate, creatine malate, and creatine-magnesium chelate
Justify the Medical Necessity The most important piece is the medical reasoning, says Giuffrida